208 related articles for article (PubMed ID: 19956747)
1. Fibroblast Growth Factor 23 (FGF23) and Disorders of Phosphate Metabolism.
Saito T; Fukumoto S
Int J Pediatr Endocrinol; 2009; 2009():496514. PubMed ID: 19956747
[TBL] [Abstract][Full Text] [Related]
2. Physiological regulation and disorders of phosphate metabolism--pivotal role of fibroblast growth factor 23.
Fukumoto S
Intern Med; 2008; 47(5):337-43. PubMed ID: 18310961
[TBL] [Abstract][Full Text] [Related]
3. [Fibroblast growth factor (FGF) 23 works as a phosphate-regulating hormone and is involved in the pathogenesis of several disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2007 Jun; 55(6):555-9. PubMed ID: 17657990
[TBL] [Abstract][Full Text] [Related]
4. [Disorders of phosphate metabolism].
Fukumoto S
Rinsho Byori; 2010 Mar; 58(3):225-31. PubMed ID: 20408440
[TBL] [Abstract][Full Text] [Related]
5. FGF23 and Bone and Mineral Metabolism.
Fukumoto S
Handb Exp Pharmacol; 2020; 262():281-308. PubMed ID: 31792685
[TBL] [Abstract][Full Text] [Related]
6. Phosphate metabolism and vitamin D.
Fukumoto S
Bonekey Rep; 2014; 3():497. PubMed ID: 24605214
[TBL] [Abstract][Full Text] [Related]
7. FGF23-FGF Receptor/Klotho Pathway as a New Drug Target for Disorders of Bone and Mineral Metabolism.
Fukumoto S
Calcif Tissue Int; 2016 Apr; 98(4):334-40. PubMed ID: 26126937
[TBL] [Abstract][Full Text] [Related]
8. [Clinical aspect of recent progress in phosphate metabolism. The pathophysiology of diseases caused by aberrant actions of FGF23].
Shimizu Y; Fukumoto S
Clin Calcium; 2009 Jun; 19(6):802-7. PubMed ID: 19483274
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 as a phosphotropic hormone and beyond.
Fukumoto S; Shimizu Y
J Bone Miner Metab; 2011 Sep; 29(5):507-14. PubMed ID: 21822586
[TBL] [Abstract][Full Text] [Related]
10. [FGF23-related hypophosphatemic rickets/osteomalacia].
Ito N; Fukumoto S
Clin Calcium; 2007 Oct; 17(10):1514-20. PubMed ID: 17906402
[TBL] [Abstract][Full Text] [Related]
11. Phosphate-sensing and regulatory mechanism of FGF23 production.
Takashi Y; Fukumoto S
J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
[TBL] [Abstract][Full Text] [Related]
12. Targeting Fibroblast Growth Factor 23 Signaling with Antibodies and Inhibitors, Is There a Rationale?
Fukumoto S
Front Endocrinol (Lausanne); 2018; 9():48. PubMed ID: 29515522
[TBL] [Abstract][Full Text] [Related]
13. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Regulation of mineral metabolism and mineralization by FGF23].
Fukumoto S
Clin Calcium; 2015 May; 25(5):687-91. PubMed ID: 25926572
[TBL] [Abstract][Full Text] [Related]
14. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment.
Kinoshita Y; Fukumoto S
Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780
[TBL] [Abstract][Full Text] [Related]
15. The role of bone in phosphate metabolism.
Fukumoto S
Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
[TBL] [Abstract][Full Text] [Related]
16. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
Liu S; Gupta A; Quarles LD
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
[TBL] [Abstract][Full Text] [Related]
17. Bone-kidney axis in systemic phosphate turnover.
Razzaque MS
Arch Biochem Biophys; 2014 Nov; 561():154-8. PubMed ID: 24997362
[TBL] [Abstract][Full Text] [Related]
18. FGF23 is a hormone-regulating phosphate metabolism--unique biological characteristics of FGF23.
Fukumoto S; Yamashita T
Bone; 2007 May; 40(5):1190-5. PubMed ID: 17276744
[TBL] [Abstract][Full Text] [Related]
19. [Rickets/Osteomalacia. FGF23-related hypophosphatemic rickets/osteomalacia.].
Fukumoto S
Clin Calcium; 2018; 28(10):1313-1317. PubMed ID: 30269112
[TBL] [Abstract][Full Text] [Related]
20. [FGF23 and skeletal metabolism].
Michigami T
Clin Calcium; 2014 Jun; 24(6):879-84. PubMed ID: 24870839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
